Market Cap | ₹10,779Cr |
ROE | 77.82% |
P/E Ratio(TTM) | 53.90 |
EPS(TTM) | 86.84 |
P/B Ratio | 41.94 |
Dividend Yield | 1.17% |
Industry P/E | 40.19 |
Book Value | 111.60 |
Debt to Equity | 0.11 |
Face Value | 10 |
Parent Organisation | Sanofi Consumer Healthcare India |
NSE Symbol | SANOFICONR |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Abbott India | NA (0.00%) | 43.61 | ||
GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 48.87 | ||
Pfizer | NA (0.00%) | 30.33 | ||
Astrazeneca Pharma India | NA (0.00%) | 124.91 |